A molecular mechanism for eflornithine resistance in African trypanosomes.
Human African trypanosomiasis, endemic to sub-Saharan Africa, is invariably fatal if untreated. Its causative agent is the protozoan parasite Trypanosoma brucei. Eflornithine is used as a first line treatment for human African trypanosomiasis, but there is a risk that resistance could thwart its use...
Enregistré dans:
Auteurs principaux: | Isabel M Vincent, Darren Creek, David G Watson, Mohammed A Kamleh, Debra J Woods, Pui Ee Wong, Richard J S Burchmore, Michael P Barrett |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2010
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/8f3e95995c734e62a7d35c0a2ca33da7 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Untargeted metabolomics reveals a lack of synergy between nifurtimox and eflornithine against Trypanosoma brucei.
par: Isabel M Vincent, et autres
Publié: (2012) -
Enantiospecific antitrypanosomal in vitro activity of eflornithine.
par: Mikael Boberg, et autres
Publié: (2021) -
The killing of African trypanosomes by ethidium bromide.
par: Arnab Roy Chowdhury, et autres
Publié: (2010) -
Early invasion of brain parenchyma by African trypanosomes.
par: Ute Frevert, et autres
Publié: (2012) -
Autoimmunity to phosphatidylserine and anemia in African Trypanosome infections.
par: Juan Rivera-Correa, et autres
Publié: (2021)